Beta-blocker therapy induces ventricular resynchronization in dilated cardiomyopathy with narrow QRS complex

J Am Coll Cardiol. 2007 Feb 20;49(7):778-83. doi: 10.1016/j.jacc.2006.05.081. Epub 2007 Feb 5.

Abstract

Objectives: We sought to evaluate the effects of beta-blocker therapy on regional and global myocardial mechanics in addition to ventricular synchrony in patients with heart failure and normal QRS by using tissue Doppler and strain echocardiography.

Background: It is unknown whether beta-blocker therapy can influence mechanical synchrony.

Methods: Conventional and strain echocardiography were performed in 15 healthy age-matched volunteers and in 25 patients with idiopathic dilated cardiomyopathy (IDC). Of these, 15 IDC patients on standard heart failure therapy were studied prior to and at 1 and 6 months after initiation of carvedilol therapy and compared to the controls.

Results: There was significant mechanical dyssynchrony in IDC compared with control patients. Patients placed on carvedilol demonstrated a significant decrease in the inferoseptal to lateral wall delay in peak strain (normalized to the R-R interval) between baseline and 1 month and between baseline and 6 months. Similarly, global time to peak segmental strain (455 +/- 51 ms vs. 423 +/- 59 ms, respectively, p = 0.02, and 455 +/- 51 ms vs. 415 +/- 50 ms, respectively, p = 0.01) and the coefficient of variation of the time to peak segmental strain decreased (17 +/- 4% vs. 15 +/- 5%, respectively, p = 0.02, and 17 +/- 4% vs. 14 +/- 5%, respectively, p = 0.03), from baseline to 1 month and between baseline and 6 months, respectively. Global strain significantly increased from baseline to 1 month (-8.2 +/- 1.8 to -10.4 +/- 3.9, respectively, p = 0.01) and between baseline and 6 months (-8.2 +/- 1.8% to -12.0 +/- 3.2%, respectively, p = 0.008). Improvements in left ventricular ejection fraction and reverse remodeling were coincident with reductions in mechanical dyssynchrony.

Conclusions: The use of carvedilol improves contractile function and dyssynchrony in heart failure patients with normal QRS.

Publication types

  • Controlled Clinical Trial

MeSH terms

  • Adrenergic beta-Antagonists / therapeutic use*
  • Adult
  • Aged
  • Blood Pressure / drug effects
  • Carbazoles / therapeutic use
  • Cardiomyopathy, Dilated / diagnosis
  • Cardiomyopathy, Dilated / drug therapy*
  • Carvedilol
  • Echocardiography, Doppler
  • Electrocardiography
  • Female
  • Heart Rate / drug effects
  • Humans
  • Male
  • Middle Aged
  • Propanolamines / therapeutic use
  • Reference Values
  • Ventricular Function / drug effects*

Substances

  • Adrenergic beta-Antagonists
  • Carbazoles
  • Propanolamines
  • Carvedilol